Lung Cancer
📧 Sign up to get email alerts when something new happens for Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001) [Phase 1, Phase 2]
AVZO-1418 is being studied as a single agent and in combination therapy for locally advanced or metastatic solid tumors in a Phase 1/2 trial…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating the safety and efficacy of a mesothelin-targeting logic-gated CAR T therapy in adults with solid tumors …
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Partial Tumor Irradiation and Immunotherapy for Unresectable Lung Cancer [NA]
A recruiting clinical trial is evaluating partial tumor irradiation in combination with immunotherapy for unresectable lung cancer, includin…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Clinical trial evaluating circulating tumor DNA as an early biomarker to assess treatment response across multiple solid tumors; currently r…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: Oncology Episode Payment Model in Hawaii [NA]
An update on an oncology episode payment model trial in Hawaii sponsored by the University of Pennsylvania. The study covers breast cancer, …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: The Florida ASCENT Study [NA]
The Florida ASCENT Study, sponsored by the University of Florida, is currently recruiting and investigates cancer outcomes in the context of…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: ICARE-LCS QUERI Partnered Evaluation Initiative: Integrating Comprehensive Tobacco Treatment to Enhance Lung Cancer Screening
Clinical trial update describing the ICARE-LCS QUERI partnered initiative to integrate comprehensive tobacco treatment to enhance lung cance…
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: A Registry for People With Lung Cancer
This entry describes a registry study at Memorial Sloan Kettering Cancer Center enrolling people with lung cancer, including stage I, to col…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma [EARLY_Phase 1]
This early-phase 1 trial evaluates the safety of dapagliflozin given before surgery in patients with Stage IA lung adenocarcinoma (a form of…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Advancing Lung Cancer Screening One Text at a Time [NA]
Recruiting update for a University of Rochester study exploring text-based methods to advance lung cancer screening.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Support for Cancer Patients Awaiting News [NA]
An ongoing clinical trial sponsored by Hackensack Meridian Health is recruiting lung cancer patients and focuses on providing support for ca…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy [NA]
VA-sponsored clinical trial evaluating lung cancer treatment options, including surgery or stereotactic radiotherapy, is currently recruitin…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of KSQ-001EX, autologous tumor infiltrating lymphocytes engineered to inactivate SOCS1, being evaluated in select advanced s…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors [Phase 1, Phase 2]
Clinical Trial Update on an ongoing Phase 1/2 study of allogeneic NK cells (EBNK-001) with low-dose interleukin-15, with or without pembroli…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Discrimination of N2a and N2b by EBUS-TBNA: is a Change of the Needle Necessary? [NA]
A University of Vienna study recruiting to assess whether changing the needle in EBUS-TBNA improves discrimination of N2a vs N2b in lung can…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung Cancer
A recruiting clinical trial evaluating molecular analysis of oncogenes and resistance mechanisms in lung cancer, sponsored by the University…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Predictive Value of a Preliminary Swallowing Test Compared to Postoperative Nasofibroscopy to Identify Vocal Cord Paralysis After Pulmonary Resection [NA]
A clinical trial (NCT05193240) is evaluating whether a preliminary swallowing test can predict vocal cord paralysis after major lung resecti…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit
This clinical trials update describes the development and clinical validation of an early-stage lung cancer prognostic kit, with recruitment…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma [Phase 1]
Phase 1 clinical trial update for TNhYP218 anti-mesothelin CAR T cells in mesothelin-expressing solid tumors, including mesothelioma; recrui…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer [NA]
A clinical trial is evaluating a Bright-light Exposure Combined With Specific Exercise Training (BEST) program in cancer patients, including…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Precise Exercise Regimen for Cancer Care (PERCC): A Pilot Study [NA]
A pilot clinical trial evaluating a precise exercise regimen for cancer care in patients with non-small cell lung cancer; the study is not y…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Formatting the Risk Prediction Models for Never-Smoking Lung Cancer
The study aims to improve risk prediction models for never-smoking lung cancer and is currently recruiting. It is sponsored by Chung Shan Me…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation [Phase 1]
This clinical trial update states that CLSP-1025 is being evaluated in a Phase 1 study for adults with solid tumors harboring the p53 R175H …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Shape-Sensing Robotic-Assisted Bronchoscopy for Diagnosis of Peripheral Pulmonary Nodules in Korea
A clinical trial in Korea is evaluating shape-sensing robotic-assisted bronchoscopy for diagnosing peripheral pulmonary nodules; the study i…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Evaluating the Impact of a Virtually Supervised Exercise Intervention and Group Counseling on Inflammation and the Microbiome of Smokers at High Risk for Lung Cancer, BE FIT Trial [NA]
The BE FIT trial investigates whether a virtually supervised exercise intervention plus group counseling affects inflammation and the microb…